Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Mark S. Lesney

    Opinion

    ID Blog: The story of syphilis, part II

    Author:
    Mark S. Lesney
    Publish date: September 19, 2019

    The transformation of syphilis from a highly lethal epidemic to a slow-burning, chronic disease provides a...

    • Read More

    News

    New engineered HIV-1 vaccine candidate shows improved immunogenicity in early trial

    Author:
    Mark S. Lesney
    Publish date: September 18, 2019

    ALVAC-HIV vaccine showed immunogenicity across several HIV clades in an early trial involving 100 healthy...

    • Read More

    News

    Hospital-acquired C. diff. tied to four ‘high-risk’ antibiotic classes

    Author:
    Mark S. Lesney
    Publish date: September 16, 2019

    High-risk antibiotics included second-, third-, and fourth-generation cephalosporins, fluoroquinolones, carbapenems, and lincosamides.

    • Read More

    News

    New genotype of S. pyrogenes found in rise of scarlet fever in U.K.

    Author:
    Mark S. Lesney
    Publish date: September 10, 2019

    The new genotype of Streptococcus pyrogenes with increased scarlet fever toxin A production became...

    • Read More

    Article

    Can we eradicate malaria by 2050?

    Author:
    Mark S. Lesney
    Publish date: September 8, 2019

    A Lancet Commission report details a series of modeled projections that could point the way.

    • Read More

    News

    Post-Ebola mortality five times higher than general population

    Author:
    Mark S. Lesney
    Publish date: September 4, 2019

    Age, area of residence (urban vs. nonurban area), and duration of stay in an Ebola treatment center were independently and significantly...

    • Read More

    Opinion

    ID Blog: The story of syphilis, part I

    Author:
    Mark S. Lesney
    Publish date: September 3, 2019

    Syphilis is on the rise again. Our blogger looks back on how it got here in the first place.

    • Read More

    News

    HCV coinfection adds to cardiovascular risk in HIV-infected patients

    Author:
    Mark S. Lesney
    Publish date: August 21, 2019

    HCV and an accumulation of other viral/bacterial coinfections were associated with the risk of developing a CV...

    • Read More

    News

    FDA approves drug combo to treat highly resistant TB

    Author:
    Mark S. Lesney
    Publish date: August 14, 2019

    The combination of pretomanid tablets with bedaquiline and linezolid primarily was approved for a limited...

    • Read More

    News

    Possible role of enterovirus infection in acute flaccid myelitis cases detected

    Author:
    Mark S. Lesney

    High levels of enterovirus peptides were found in the cerebral spinal fluid of individuals with AFM.

    • Read More

    News

    Favorable Ebola results lead to drug trial termination, new focus

    Author:
    Mark S. Lesney
    Publish date: August 12, 2019

    Two of four therapeutics showed greater Ebola survival, prompting termination of the initial trial and...

    • Read More

    News

    AHA highlights limitations of perfusion testing for critical limb ischemia

    Author:
    Mark S. Lesney
    Publish date: August 12, 2019

    Perfusion assessment techniques for CLI remain limited and major differences in assessment, comorbidities, and...

    • Read More

    News

    HCV-infected people who inject drugs also have substantial alcohol use

    Author:
    Mark S. Lesney
    Publish date: August 6, 2019

    Moderate (21%) and heavy (38%) alcohol use was common in HCV-infected people who injected drugs.

    • Read More

    News

    DRC Ebola epidemic continues unabated despite international response

    Author:
    Mark S. Lesney
    Publish date: August 2, 2019

    HHS summarized the U.S. response to Ebola on the 1-year anniversary of the latest outbreak, which continues unabated in the Democratic Republic of...

    • Read More

    News

    Spleen/liver stiffness ratio differentiates HCV, ALD

    Author:
    Mark S. Lesney
    Publish date: July 23, 2019

    The SS/LS ratio is significantly higher in patients with HCV than in those with alcohol-related liver disease (ALD).

    • Read More

    Pages

    • « first
    • …
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery